TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern” September 26, 2014